Is your Environmental Monitoring Annex 1 Compliant?

Is your Environmental Monitoring Annex 1 Compliant?
next

January 3, 2025 1:49 PM

As the clock ticks down to the 25th August 2023, when the latest revision of EU GMP Annex 1 takes effect, we are reflecting on the impact of those changes to our customer’s Environmental Monitoring Systems, and how Pharmagraph can enable them to maintain compliance.

After 14 years of development, the revised requirements govern the manufacturing of sterile drugs made in the EU, as well as imported products. The Annex has been revised to “reflect changes in regulatory and manufacturing environments. The new guideline should clarify how manufacturers can take advantage of new possibilities deriving from the application of an enhanced process understanding by using innovative tools as described in the ICH Q9 and Q10 guidelines.” *

The final revision of Annex 1 represents an extensive rewrite of the original 2008 version, with a page count increase from 16 to 58. The Annex includes sections covering scope, principles, pharmaceutical quality system (PQS), premises, equipment, utilities, personnel, production and specific technologies, environmental and process monitoring, and quality control.

The new version places a strong focus on risk management and having an overall contamination control strategy (CCS). Furthermore, the CCS should directly influence the environmental monitoring programme deployed and the associated data collected plays a key role. Ongoing monitoring data should be reviewed to identify any adverse trends in system performance.

Alongside the overall CCS, another area of particular concern are the new requirements to ensure that particle count tube length should be no longer than 1m unless justified, and the number of bends should be minimized.

To assist our customers in achieving Annex 1 readiness Pharmagraph are offering an Annex 1 Site Survey by one of our expert EMS engineers. This survey covers a documented procedure which reviews both key hardware and software status with the findings and key risk areas published in a summary report within 5 days of visit.

For more information or to book an Annex 1 Site Survey please contact our sales team via sales@pharmagraph.co.uk

*The Rules Governing Medicinal Products in the European Union Volume 4 EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use
Annex 1 – Manufacture of Sterile Medicinal Products

Find Out More

You might also be interested in...

Pharmagraph Enhances iVAS Air Sampler

Pharmagraph Enhances iVAS Air Sampler with Support for 25 lpm Flow Rates

Pharmagraph is pleased to announce a significant upgrade to its innovative iVAS active air sampler. The iVAS system now supports operation at 25 litres per minute (lpm), delivering increased flexibility and extended sampling durations for customers working in compliance with the EU GMP Annex 1 regulations for sterile manufacturing environments.

Find out more
Pharmagraph Achieves ISO 14001 Environmental Management Certification

Pharmagraph Achieves ISO 14001 Environmental Management Certification

Pharmagraph, and its parent company Acquisition Systems Ltd, have officially been granted ISO 14001:2015 accreditation for Environmental Management.

Find out more
Pharmagraph Partner with CompuCal Calibration Solutions

Pharmagraph Partner with CompuCal Calibration Solutions

Pharmagraph are delighted to partner with CompuCal Calibration Solutions, utilising their Calibration Management Software to digitise Pharmagraph’s calibration program.

Find out more
Pharmagraph Exhibiting at QATS Annual Symposium 2024

Pharmagraph Exhibiting at QATS Annual Symposium 2024

We are please to be returning to the QATS Annual Symposium on Thursday 17th and Friday 18th October 2024.

Find out more

Who We Are. What We Deliver.

From decades of industry experience to the systems we build today, everything we do is grounded in compliance, performance, and trust. Join us behind the scenes of world-class pharmaceutical monitoring, and help shape the solutions that keep our partners ahead.